View in EDS HTML Full Text PDF Full Text

CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth.

Saved in:
Bibliographic Details
Title: CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth.
Authors: Lin, Yihua1 (AUTHOR), Zhao, Yiling1 (AUTHOR), Chen, Minggui1 (AUTHOR), Li, Zishuo1 (AUTHOR), Liu, Qiao1 (AUTHOR), Chen, Jian1 (AUTHOR), Ding, Yi1 (AUTHOR), Ding, Chunyong2 (AUTHOR), Ding, Ye2 (AUTHOR), Qi, Cuiling1 (AUTHOR), Zheng, Lingyun1 (AUTHOR), Li, Jiangchao1 (AUTHOR), Zhang, Rongxin1 (AUTHOR), Zhou, Jia2 (AUTHOR) jizhou@utmb.edu, Wang, Lijing1 (AUTHOR) wanglijing62@163.com, Zhang, Qian-Qian1 (AUTHOR) vinny223@126.com
Source: BMC Cancer. 5/26/2023, Vol. 23 Issue 1, p1-18. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-023-10974-4